Finance

Beta
Lists
OTLC:OTCMKTS
Oncotelic Therapeutics Inc
USD 0,045
+9,49%
(+0,0039) 1D
17 Jun., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLC...
Open
USD 0,04
High
USD 0,05
Low
USD 0,04
Mkt. cap
20,55 m
Avg. vol.
300,14 k
Volume
400,35 k
P/E ratio
0,08
52-wk high
USD 0,11
52-wk low
USD 0,02
EPS
USD 0,55
Beta
-0,33
Shares outstanding
444,50 m
No. of employees
41
Open
USD 0,04
High
USD 0,05
Low
USD 0,04
Mkt. cap
20,55 m
Avg. vol.
300,14 k
Volume
400,35 k
P/E ratio
0,08
52-wk high
USD 0,11
52-wk low
USD 0,02
EPS
USD 0,55
Beta
-0,33
Shares outstanding
444,50 m
No. of employees
41
News stories
From sources across the web
About Oncotelic Therapeutics Inc
CEO-
Employees41
Founded1988
HeadquartersSouth San Francisco, Kalifornië, Verenigde State van Amerika
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
297,00
426,00
3,34 k
795,00
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
65,67 k
490,55 k
2,33 m
1,85 m
Operating expense
65,97 k
490,97 k
2,33 m
1,85 m
Total operating expenses
65,97 k
490,97 k
2,33 m
1,85 m
Operating income
-65,97 k
-490,97 k
-2,33 m
-1,85 m
Other non operating income
484,20 k
-392,06 k
326,43 k
-90,08 k
EBT including unusual items
210,45 k
-1,11 m
361,84 m
-2,24 m
EBT excluding unusual items
210,45 k
-1,11 m
-2,24 m
-2,24 m
Income tax expense
-
-
111,55 m
-
Effective tax rate
-
-
30,83%
-
Other operating expenses
-
-
-
-
Net income
277,86 k
-1,05 m
250,35 m
-2,19 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-207,78 k
-231,34 k
-242,57 k
-295,81 k
Net interest expenses
-207,78 k
-231,34 k
-242,57 k
-295,81 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more